九州大学 研究者情報
著書一覧
本庄 雅則(ほんしよう まさのり) データ更新日:2023.12.05

教授 /  医学研究院 加齢病態修復学講座


著書
1. 本庄雅則, 個体におけるエーテル型リン脂質プラスマローゲンの生合成制御機構と生理機能の解明, ニューサイエンス社, Medical Science Digest Vol 48 (1) , 2022, 2022.01.
2. Okumoto K., Tamura S., Honsho M., and Fujiki Y., Peroxisome: Metabolic Functions and Biogenesis, Springer, Cham, 10.1007/978-3-030-60204-8_1, Lizard G. (eds) Peroxisome Biology: Experimental Models, Peroxisomal Disorders and Neurological Diseases. Advances in Experimental Medicine and Biology, vol 1299, 3-17, 2021.01, [URL], Peroxisome is an organelle conserved in almost all eukaryotic cells with a variety of functions in cellular metabolism, including fatty acid β-oxidation, synthesis of ether glycerolipid plasmalogens, and redox homeostasis. Such metabolic functions and the exclusive importance of peroxisomes have been highlighted in fatal human genetic disease called peroxisomal biogenesis disorders (PBDs). Recent advances in this field have identified over 30 PEX genes encoding peroxins as essential factors for peroxisome biogenesis in various species from yeast to humans. Functional delineation of the peroxins has revealed that peroxisome biogenesis comprises the processes, involving peroxisomal membrane assembly, matrix protein import, division, and proliferation. Catalase, the most abundant peroxisomal enzyme, catalyzes decomposition of hydrogen peroxide. Peroxisome plays pivotal roles in the cellular redox homeostasis and the response to oxidative stresses, depending on intracellular localization of catalase..
3. Abe Y., Tamura S., Honsho M., and Fujiki Y., A Mouse Model System to Study Peroxisomal Roles in Neurodegeneration of Peroxisome Biogenesis Disorders, Springer, Cham, 10.1007/978-3-030-60204-8_10, Lizard G. (eds) Peroxisome Biology: Experimental Models, Peroxisomal Disorders and Neurological Diseases. Advances in Experimental Medicine and Biology, vol 1299, 119-143, 2021.01, [URL], Fourteen PEX genes are currently identified as genes responsible for peroxisome biogenesis disorders (PBDs). Patients with PBDs manifest as neurodegenerative symptoms such as neuronal migration defect and malformation of the cerebellum. To address molecular mechanisms underlying the pathogenesis of PBDs, mouse models for the PBDs have been generated by targeted disruption of Pex genes. Pathological phenotypes and metabolic abnormalities in Pex-knockout mice well resemble those of the patients with PBDs. The mice with tissue- or cell type-specific inactivation of Pex genes have also been established by using a Cre-loxP system. The genetically modified mice reveal that pathological phenotypes of PBDs are mediated by interorgan and intercellular communications. Despite the illustrations of detailed pathological phenotypes in the mutant mice, mechanistic insights into pathogenesis of PBDs are still underway. In this chapter, we overview the phenotypes of Pex-inactivated mice and the current understanding of the pathogenesis underlying PBDs..
4. Honsho M., Okumoto K., Tamura S., and Fujiki Y., Peroxisome Biogenesis Disorders, Springer, Cham, 10.1007/978-3-030-60204-8_4, Lizard G. (eds) Peroxisome Biology: Experimental Models, Peroxisomal Disorders and Neurological Diseases. Advances in Experimental Medicine and Biology, vol 1299, 45-54, 2021.01, [URL], Peroxisomes are presented in all eukaryotic cells and play essential roles in many of lipid metabolic pathways, including β-oxidation of fatty acids and synthesis of ether-linked glycerophospholipids, such as plasmalogens. Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs). Fourteen complementation groups of PBDs are found, and their complementing genes termed PEXs are isolated. Several new mutations in peroxins from patients with mild PBD phenotype or patients with phenotypes unrelated to the commonly observed impairments of PBD patients are found by next-generation sequencing. Exploring a dysfunctional step(s) caused by the mutation is important for unveiling the pathogenesis of novel mutation by means of cellular and biochemical analyses..
5. 本庄雅則, 藤木幸夫, プラスマローゲン恒常性とその障害による疾患 , 医歯薬出版, 医学のあゆみ 第5土曜特集『脂質クオリティ:研究の基礎と臨床』 Vol. 269, No. 13, 1103-1107, 2019.06, [URL].
6. Honsho M. and Fujiki Y., Homeostasis of Plasmalogens in Mammals, Elsevier Inc., 10.1016/B978-0-08-100596-5.21664-8, Encyclopedia of Food Chemistry, Elsevier Inc., Waltham, USA. Vol. 2, 218-223, 2019.01, [URL], Ethanolamine-containing alkenyl ether glycerophospholipid, plasmalogen, is characterized by the presence of vinyl-ether linkage at the sn-1 position. Plasmalogens are found in nearly all mammalian tissues, and important components of cellular membranes. De novo synthesis of plasmalogens initiated in peroxisomes plays a pivotal role in the homeostasis of cellular plasmalogens. Synthesis of plasmalogens is regulated by feedback mechanism via sensing the plasmalogens located in the inner leaflet of plasma membranes, followed by modulating the level of fatty acyl-CoA reductase 1, the enzyme responsible for the synthesis of long-chain alcohols which are essential for the ether-bond formation in peroxisomes. Plasmalogens can be synthesized from alkylglycerol in cells and peripheral tissues such as liver and heart in rodent, whereas plasmalogens essential for the function of brain are more likely supplied by de novo synthesis in brain rather than the transport of peripherally synthesized plasmalogens by crossing blood brain barrier, implying that regulation of plasmalogen synthesis plays an important role in the homeostasis of brain plasmalogens..
7. 本庄雅則, 藤木幸夫, ペルオキシソームの恒常性と生理機能制御 , 日本生化学会, 10.14952/SEIKAGAKU.2018.900005, 生化学 特集:「オルガネラの生物機能と疾患における破綻機構」 Vol. 90 No. 1, 5-13, 2018.02, [URL].
8. 藤木幸夫, 山下俊一, 奥本寛治, 本庄雅則, ペキソファジー:ペルオキシソームの形成・機能制御と分解機構 , 羊土社, 実験医学 7月号特集『ユビキチン化を介したオルガネロファジー』 Vol. 35 No. 11, 1824-1831, 2017.06, [URL].
9. Honsho M., and Fujiki Y., Analysis of Plasmalogen Synthesis in Cultured Cells, Humana, 10.1007/978-1-4939-6937-1_6, Schrader, M. (ed.) Peroxisomes: Methods and Protocols, Methods in Molecular Biology 55-61, 2017.01, [URL], Plasmalogen synthesis can be analyzed by metabolic labeling, followed by the separation of ethanolamine plasmalogens from glycerophospholipids on one-dimensional thin-layer chromatography. The vinyl-ether bond of plasmalogens is acid-labile, which allows separating plasmalogens as 2-acyl-glycerophospholipids from diacyl-glycerophospholipids..
10. Liu Y., Honsho M., and Fujiki Y., In Vitro PMP Import Analysis Using Cell-Free Synthesized PMP and Isolated Peroxisomes, Humana, 10.1007/978-1-4939-6937-1_19, Schrader, M. (ed.) Peroxisomes: Methods and Protocols, Methods in Molecular Biology 207-212, 2017.01, [URL], The Pex19p- and Pex3p-dependent direct import of peroxisomal membrane proteins (PMPs), termed the class I pathway, can be reconstituted in vitro by incubating cell-free synthesized PMPs with highly purified peroxisomes at 26 °C for 1 h. This method ensures that the proteins targeted to peroxisomes are imported directly without involvement of other organelles..
11. Okumoto K., Honsho M., Liu Y., and Fujiki Y., Peroxisomal Membrane and Matrix Protein Import Using a Semi-Intact Mammalian Cell System, Humana, 10.1007/978-1-4939-6937-1_20, Schrader, M. (ed.) Peroxisomes: Methods and Protocols, Methods in Molecular Biology 213-219, 2017.01, [URL], Peroxisomes are essential intracellular organelles that catalyze a number of essential metabolic pathways including β-oxidation of very long chain fatty acids, synthesis of plasmalogen, bile acids, and generation and degradation of hydrogen peroxide. These peroxisomal functions are accomplished by strictly and spatiotemporally regulated compartmentalization of the enzymes catalyzing these reactions. Defects in peroxisomal protein import result in inherited peroxisome biogenesis disorders in humans. Peroxisomal matrix and membrane proteins are synthesized on free ribosomes and transported to peroxisomes in a manner dependent on their specific targeting signals and their receptors. Peroxisomal protein import can be analyzed using a semi-intact assay system, in which targeting efficiency is readily monitored by immunofluorescence microscopy. Furthermore, cytosolic factors required for peroxisomal protein import can be manipulated, suggesting that the semi-intact system is a useful and convenient system to uncover the molecular mechanisms of peroxisomal protein import..
12. 藤木幸夫, 奥本寛治, 本庄雅則, ペルオキシソーム形成異常と疾患, 医歯薬出版, 別冊・医学のあゆみ 特集「ストレスシグナルと疾患―細胞恒常性維持機構の破綻と病態」 75-79, 2016.07, [URL].
13. 藤木幸夫, 本庄雅則, エーテルリン脂質プラスマローゲンの生合成とその障害, 日本機能性食品医用学会, 機能性食品と薬理栄養 特集「プラズマローゲンと神経機能」 Vol. 9 No. 5, 322-327, 2016.02, [URL].
14. 藤木幸夫, 奥本寛治, 本庄雅則, ペルオキシソーム形成異常と疾患, 医歯薬出版, 医学のあゆみ 特集「細胞内小器官とストレス」 Vol. 254 No. 5, 397-401, 2015.08, [URL].
15. Fujiki Y., Okumoto K., and Honsho M., Protein Import into Peroxisomes: The Principles and Methods of Studying (version 2.0), John Wiley & Sons, 10.1002/9780470015902.a0002618.pub2, Encyclopedia of Life Sciences, 2015.04, [URL], Peroxisomes are essential intracellular organelles that involve many metabolic processes, such as β‐oxidation of very long‐chain fatty acids and synthesis of plasmalogen and bile acids as well as generation and degradation of hydrogen peroxide. These peroxisomal functions are fulfilled by strictly and spatiotemporally regulated compartmentation of the proteins catalysing these reactions. Defects in peroxisomal protein import results in inherited peroxisome biogenesis disorders in humans. Peroxisomal matrix and membrane proteins are synthesised on free ribosomes but transported into peroxisomes by distinct pathways determined by specific targeting signals and their receptors. The mechanism by which this is achieved has been clarified by identification of many PEX genes and the products named peroxins, the essential factors for peroxisome biogenesis. This article introduces several basic methods to investigate protein import into peroxisomes..
16. Fujiki Y., Itoyama A., Abe Y., and Honsho M., Molecular Complex Coordinating Peroxisome Morphogenesis in Mammalian Cells , Springer-Verlag Wien, 10.1007/978-3-7091-1788-0_17, Brocard, C. and Hartig, A. (eds) Molecular machines involved in peroxisome biogenesis and maintenance, Springer-Verlag, Wien, Austria. 391-401, 2014.05, [URL], Peroxisomal division comprises three stages: elongation, constriction, and fission. Potential candidates thus far studied for the factors involved in these stages include Pex11pβ, dynamin-like protein 1 (DLP1), mitochondrial fission factor (Mff), and Fission 1 (Fis1). A poly-unsaturated fatty acid of peroxisomal β-oxidation metabolites, docosahexaenoic acid (C22:6n-3), augments hyper-oligomerization of Pex11pβ that gives rise to peroxisomal elongation, a prerequisite for subsequent fission and peroxisome division. Translocation of DLP1, a member of the large GTPase family, from the cytosol to peroxisomes is a prerequisite for membrane fission. However, the molecular machinery for peroxisomal targeting of DLP1 remains elusive. Mff is also localized to peroxisomes, especially at the membrane-constricted regions of elongated peroxisomes. Knockdown of Mff abrogates the fission stage of peroxisomal division and fails to recruit DLP1 to peroxisomes, while ectopic expression of Mff increases the peroxisomal targeting of DLP1. Co-expression of Mff and Pex11pβ increases peroxisome abundance. Overexpression of Mff also increases the interaction between DLP1 and Pex11pβ, which knockdown of Mff, but not Fis1, abolishes. Moreover, Pex11pβ interacts with Mff in a DLP1-dependent manner. Mff contributes to the peroxisomal targeting of DLP1 and plays a key role in the fission of the peroxisomal membrane by acting in concert with Pex11pβ and DLP1. The investigations performed to date suggest that a functional complex comprising Pex11pβ, Mff, and DLP1 promotes Mff-mediated fission during peroxisomal division. With regard to peroxisome morphogenesis, we address recent issues and findings and propose a model for peroxisome division..
17. 藤木幸夫, 本庄雅則, ペルオキシソームの脂質代謝, 医歯薬出版, 医学のあゆみVol. 248 No. 13, 1143-1149, 2014.03, [URL].
18. 藤木幸夫, 宮田暖, 奥本寛治, 田村茂彦, 糸山彰徳, 本庄雅則, ペルオキシソームの形成・制御とその障害, 医学書院, 10.11477/mf.2425101352, 生体の科学 特集「細胞の分子構造と機能―核以外の細胞小器官」 Vol. 63 No. 5, 448-451, 2012.10, [URL].
19. 藤木幸夫, 宮田暖, 松園裕嗣, 松崎高志, 本庄雅則, ペルオキシソームの形成・制御とその障害による高次機能の破綻, 羊土社, 実験医学 Vol. 28 No. 13, 2094-2101, 2010.07, [URL].
20. Schuck S., Honsho M., and Simons K., Detergent-Resistant Membranes and the Use of Cholesterol Depletion, Elsevier Inc., 10.1016/B978-012164730-8/50073-3, Cell Biology : A Laboratory Handbook 2, 5-9, 2006.12, [URL].
21. 藤木幸夫, 向井悟, 本庄雅則, ペルオキシソーム形成の分子基盤, 羊土社, 実験医学増刊 Vol. 21 No. 14, 1904-1911, 2003.09, [URL].

九大関連コンテンツ

pure2017年10月2日から、「九州大学研究者情報」を補完するデータベースとして、Elsevier社の「Pure」による研究業績の公開を開始しました。